# Oric Pharmaceuticals, Inc. (ORIC) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Oric Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ORIC/mda/fy2025/): filed 2026-02-23; accession 0001193125-26-064005 (https://www.sec.gov/Archives/edgar/data/1796280/000119312526064005/oric-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ORIC/mda/fy2024/): filed 2025-02-18; accession 0000950170-25-022273 (https://www.sec.gov/Archives/edgar/data/1796280/000095017025022273/oric-20241231.htm)
- [FY 2023 MD&A](/company/ORIC/mda/fy2023/): filed 2024-03-11; accession 0000950170-24-029298 (https://www.sec.gov/Archives/edgar/data/1796280/000095017024029298/oric-20231231.htm)
- [FY 2022 MD&A](/company/ORIC/mda/fy2022/): filed 2023-03-16; accession 0000950170-23-008483 (https://www.sec.gov/Archives/edgar/data/1796280/000095017023008483/oric-20221231.htm)
- [FY 2021 MD&A](/company/ORIC/mda/fy2021/): filed 2022-03-21; accession 0000950170-22-004239 (https://www.sec.gov/Archives/edgar/data/1796280/000095017022004239/oric-20211231.htm)

Back to /company/ORIC/